227 related articles for article (PubMed ID: 36634811)
1. Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.
Defilippi CR; Alemayehu WG; Voors AA; Kaye D; Blaustein RO; Butler J; Ezekowitz JA; Hernandez AF; Lam CSP; Roessig L; Seliger S; Shah P; Westerhout CM; Armstrong PW; O'Connor CM;
J Card Fail; 2023 Apr; 29(4):448-458. PubMed ID: 36634811
[TBL] [Abstract][Full Text] [Related]
2. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.
Butler J; Zheng Y; Khan MS; Bonderman D; Lund LH; deFilippi CR; Blaustein RO; Ezekowitz JA; Freitas C; Hernandez AF; O'Connor CM; Voors AA; Westerhout CM; Lam CSP; Armstrong PW;
JACC Heart Fail; 2023 May; 11(5):583-592. PubMed ID: 37137660
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
Armstrong PW; Roessig L; Patel MJ; Anstrom KJ; Butler J; Voors AA; Lam CSP; Ponikowski P; Temple T; Pieske B; Ezekowitz J; Hernandez AF; Koglin J; O'Connor CM
JACC Heart Fail; 2018 Feb; 6(2):96-104. PubMed ID: 29032136
[TBL] [Abstract][Full Text] [Related]
5. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction.
Mentz RJ; Stebbins A; Butler J; Chiang CE; Ezekowitz JA; Hernandez AF; Hilkert R; Lam CSP; McDonald K; O'Connor CM; Pieske B; Ponikowski P; Roessig L; Sweitzer NK; Voors AA; Anstrom KJ; Armstrong PW;
JACC Heart Fail; 2024 May; 12(5):839-846. PubMed ID: 38363272
[TBL] [Abstract][Full Text] [Related]
7. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.
Pieske B; Patel MJ; Westerhout CM; Anstrom KJ; Butler J; Ezekowitz J; Hernandez AF; Koglin J; Lam CSP; Ponikowski P; Roessig L; Voors AA; O'Connor CM; Armstrong PW;
Eur J Heart Fail; 2019 Dec; 21(12):1596-1604. PubMed ID: 31820546
[TBL] [Abstract][Full Text] [Related]
8. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
9. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
Gheorghiade M; Greene SJ; Butler J; Filippatos G; Lam CS; Maggioni AP; Ponikowski P; Shah SJ; Solomon SD; Kraigher-Krainer E; Samano ET; Müller K; Roessig L; Pieske B;
JAMA; 2015 Dec; 314(21):2251-62. PubMed ID: 26547357
[TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial.
Packer M; Januzzi JL; Ferreira JP; Anker SD; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Jamal W; Cotton D; Iwata T; Zannad F;
Eur J Heart Fail; 2021 Sep; 23(9):1529-1538. PubMed ID: 34053177
[TBL] [Abstract][Full Text] [Related]
11. Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction.
Koppen E; Omland T; Larsen AI; Karlsen T; Linke A; Prescott E; Halle M; Dalen H; Delagardelle C; Hole T; van Craenenbroeck EM; Beckers P; Ellingsen Ø; Feiereisen P; Valborgland T; Videm V;
ESC Heart Fail; 2021 Jun; 8(3):2183-2192. PubMed ID: 33754453
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
13. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
Pieske B; Maggioni AP; Lam CSP; Pieske-Kraigher E; Filippatos G; Butler J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Gheorghiade M
Eur Heart J; 2017 Apr; 38(15):1119-1127. PubMed ID: 28369340
[TBL] [Abstract][Full Text] [Related]
14. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial.
Chew DS; Li Y; Bigelow R; Cowper PA; Anstrom KJ; Daniels MR; Davidson-Ray L; Hernandez AF; O'Connor CM; Armstrong PW; Mark DB;
Circulation; 2023 Oct; 148(14):1087-1098. PubMed ID: 37671551
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis.
Trujillo ME; Arrington L; Patel Y; Passarell J; Wenning L; Blaustein RO; Armstrong PW; Meyer M; Becker C; Gheyas F
Clin Pharmacol Ther; 2022 Nov; 112(5):1061-1069. PubMed ID: 35841202
[TBL] [Abstract][Full Text] [Related]
17. Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.
Lam CSP; Piña IL; Zheng Y; Bonderman D; Pouleur AC; Saldarriaga C; Pieske B; Blaustein RO; Nkulikiyinka R; Westerhout CM; Armstrong PW;
JACC Heart Fail; 2023 Sep; 11(9):1246-1257. PubMed ID: 37565973
[TBL] [Abstract][Full Text] [Related]
18. Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial.
Voors AA; Mulder H; Reyes E; Cowie MR; Lassus J; Hernandez AF; Ezekowitz JA; Butler J; O'Connor CM; Koglin J; Lam CSP; Pieske B; Roessig L; Ponikowski P; Anstrom KJ; Armstrong PW;
Eur J Heart Fail; 2021 Aug; 23(8):1313-1321. PubMed ID: 33999486
[TBL] [Abstract][Full Text] [Related]
19. Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Pocock SJ; Ferreira JP; Packer M; Zannad F; Filippatos G; Kondo T; McMurray JJV; Solomon SD; Januzzi JL; Iwata T; Salsali A; Butler J; Anker SD
Eur J Heart Fail; 2022 Oct; 24(10):1869-1878. PubMed ID: 35796209
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
